Breaking ties

TV>> MONSANTO • India

Rajasthan seed initiative wilts

MoUs with biotech seed companies in limbo as protests force a rethink

States’ entry ruffles GM lobby

Biotech firms object to states getting a say in approving GM crop trials

Rajasthan scraps seed pacts

ICAR tells Rajasthan to wait for guidelines on benefit sharing, biosafety

ABCDE of Obama’s sales pitch

Scientifically invalid

Inter-Academy update on GM crops does little to redeem Indian science

Rajasthan opens farm gates

State ties up with Monsanto, other biotech giants to restructure agriculture

Whose germplasm is it?

NBA struggles to frame case against Mahyco in first biopiracy case

A pre-emptive strike against Monsanto

American organic farmers are trying to ensure the biotech giant cannot sue them

In the wrong ministry?

Biotech Regulatory Authority will have too much power, no checks

Letters

Reluctant funding

Compromise on resources salvages CBD conference; marine protection gets big boost

WHO OWNS OUR VEGGIES?

The patenting of a broccoli developed through conventional breeding in Europe is a disturbing trend since it violates the law on plant life

Seeds of decline

Frequent pest attacks, rising seed costs and declining returns are forcing farmers to abandon India's first genetically modified (GM) crop, Bt …

Why do we need patents?

There is no empirical evidence that patents serve to increase innovation and productivity

'Failing to support GM crops single most damaging element for growth'

The European Association for Bio-Industries (EuropaBio) says the decision by 16 EU nations to opt out of GMO crop cultivation has taken away the …

Rotten tomato for Monsanto

US biotech giant's claim on a natural tomato is its latest patent to be revoked by Europe after soy and wheat

Why experts want GM freeze

Say regulatory system has grave deficiencies; challenge agriculture ministry’s claims

Regulatory battle

Industry and activists have expressed conflicting opinions on GM crops. GEAC has a difficult decision to make

Access, yes. Sharing, no

The access and benefit-sharing protocol on biodiversity may do little to deter multinationals from grabbing the planet’s resources

It’s still open season for bio-piracy

Rich nations block accord on benefit-sharing rules for the world’s genetic resources

Moily bats for GM trials

After he revives regulatory body for GM crops, industry demands removal of state clearances

Disclosure-shy industry

Pharma and biotech firms are lobbying hard to block disclosure of origin of genetic material used in inventions, but they also raise thorny issues

The GM maize rats

Findings of the Seralini lab on effect of Monsanto’s GM maize on rats set off a global furore

Biotech industry has a new patron

Department of Biotechnology is playing venture capitalist to private companies to push biotech research in agriculture